Mechanism of Action of Ocrelizumab in Multiple Sclerosis

Clinical trial NCT03344094 · COMPLETED

Trial details

NCT number: NCT03344094
Sponsor: University of Chicago
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis Immune System Diseases

Start date: 2018-02-23
Primary completion: 2019-04-10
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.